Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein L (hnRNP L)

Target
hnRNP L
Molecular classification
RNA-binding protein, Splicing factor, Pre-mRNA processing protein, Other
01

Overview

Heterogeneous nuclear ribonucleoprotein L (hnRNP L) is an abundant nuclear protein encoded by the HNRNPL gene that belongs to the hnRNP superfamily, which is essential in RNA metabolism[1][6][8]. hnRNP L contains four RNA recognition motif (RRM) domains that mediate specific binding to CA-repeat or CA-rich RNA sequences and is a core component of hnRNP complexes critical for the formation, packaging, processing, and function of precursor and mature mRNA[1][5]. Beyond splicing, hnRNP L regulates mRNA stabilization, IRES-mediated translation, and is implicated in DNA repair, particularly during processes such as class switch recombination in immunoglobulin genes and response to DNA damage in cancer cells[7]. It interacts with other hnRNPs and key splicing factors, and its location can shift from nucleus to cytoplasm in response to stimuli such as hypoxia[3][5]. Aberrant expression or mislocalization of hnRNP L is associated with various disease states, especially certain cancers and viral infections, and it may play a pathophysiological role in neurological disorders[6]. While not a current direct drug target, its regulatory functions in gene expression, splicing, and translation underscore its centrality to fundamental cellular processes and disease mechanisms.

Other names
HNRNPLheterogeneous nuclear ribonucleoprotein LhnRNP Lheterogeneous ribonucleoprotein L
02

Mechanism of action

Blockade of RNA-protein interactions (e.g., RNA aptamer binding to hnRNP L inhibits viral RNA translation); Modulation of pre-mRNA alternative splicing; Regulation of DNA repair processes

03

Biological functions

RNA bindingmRNA splicing and alternative splicingmRNA stabilizationmRNA transportRegulation of translation (including internal ribosome entry site— IRES—mediated translation)Regulation of gene expressionDNA repairApoptosis regulationChromatin organization
04

Disease associations

CancerViral infection (e.g., hepatitis C virus, foot-and-mouth disease virus)Neurodevelopmental disorders (e.g., autism spectrum disorder, epilepsy)Other
05

Safety considerations

Targeting hnRNP L could present significant risks due to its fundamental and widespread roles in mRNA processing and gene regulation, possibly affecting normal cell function and viability.
06

Interacting drugs

No approved therapeutic drugs directly target hnRNP L. However, research shows RNA aptamers can modulate its activity in the context of hepatitis C virus infection[3].
07

Biomarkers

There are no established clinical biomarkers for patient selection or efficacy monitoring specific to hnRNP L, but altered expression may have biomarker potential in cancer research and in-virus associated pathogenesis.

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein L (hnRNP L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein L (hnRNP L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call